Insulin pumps backed by NICE

Insulin pump therapy has been approved for patients with type-1 diabetes, according to preliminary NICE guidance.

Both children and adults with difficult to control type-1 diabetes could be eligible for continuous subcutaneous insulin infusion (CSII).

Under-11s can be given the treatment if multiple-dose insulin (MDI) therapy is inappropriate.

Older patients are eligible for CSII if they find it impossible to maintain a HbA1c of 8.5 per cent or less using MDI or they suffer from recurrent and unpredictable hypoglycaemic events, says NICE.

CSII uses an external pump to continuously deliver insulin to the patient. It can be programmed to ensure insulin is delivered at higher rates at meal times, or has different basal rates in the day or night.

The NICE appraisal committee says evidence shows CSII has a valuable effect on HbA1c levels and can reduce the rate of hypoglycaemic episodes.

CSII can only be initiated by specialist teams, says NICE.

Professor Mike Kirby, a GP with an interest in diabetes, said: 'It's good news. It's been a battle to get funding for this in the past.'

Therapy eligibility

  • Type-1 diabetes patients.
  • Under-11s who have difficulty using MDI.
  • Over-11s and adults who have HbA1c >8.5 per cent.
  • Over-11s and adults with recurrent hypoglycaemia.

rachel.liddle@haymarket.com

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Pension tax solution for judges shows government could do more for doctors, says BMA

Pension tax solution for judges shows government could do more for doctors, says BMA

Government plans to 'effectively exempt judges from pension tax' show the government...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Second-phase COVID-19 vaccine rollout maintains prioritisation by age

Second-phase COVID-19 vaccine rollout maintains prioritisation by age

The Joint Committee on Vaccination and Immunisation (JCVI) has published advice on...

PCNs paid £70m for first-wave COVID-19 jab campaign as NHS plots next phase of rollout

PCNs paid £70m for first-wave COVID-19 jab campaign as NHS plots next phase of rollout

Primary care network (PCN) COVID-19 vaccination sites have been paid £70m this month...

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP personally calling at-risk patients to boost COVID-19 vaccine uptake

London GP Dr Farzana Hussain is personally telephoning scores of patients who have...

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Half of patients with possible cancer symptoms avoided contacting GP in first wave

Almost half of people who experienced potential cancer symptoms in the first wave...